- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Infectious Disease Vaccine Adjuvants
Authors
Keywords
-
Journal
Vaccines
Volume 10, Issue 7, Pages 1120
Publisher
MDPI AG
Online
2022-07-14
DOI
10.3390/vaccines10071120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy
- (2022) Chi Zhang et al. MOLECULES
- Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
- (2022) Aroosa Younis Nadeem et al. Vaccines
- Granulocyte macrophage colony-stimulating factor has come of age: from a vaccine adjuvant to antiviral immunotherapy
- (2021) Maria Petrina et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines
- (2021) Charles C. Dai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
- (2021) Peter Richmond et al. LANCET
- Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
- (2021) Saghi Nooraei et al. JOURNAL OF NANOBIOTECHNOLOGY
- Natural and Synthetic Saponins as Vaccine Adjuvants
- (2021) Pengfei Wang Vaccines
- Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base
- (2021) Jean B. Nachega et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2021) Keith J Chappell et al. LANCET INFECTIOUS DISEASES
- Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
- (2021) Prabhu S. Arunachalam et al. NATURE
- Emerging concepts in the science of vaccine adjuvants
- (2021) Bali Pulendran et al. NATURE REVIEWS DRUG DISCOVERY
- Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection
- (2021) Ismail Cem Yilmaz et al. ALLERGY
- Adjuvant properties of IFN-γ and GM-CSF in the scFv6.C4 DNA vaccine against CEA-expressing tumors
- (2021) Bianca Ferrarini Zanetti et al. GENE THERAPY
- Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review
- (2021) Khatereh Asadi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
- (2021) Jorrit De Waele et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
- (2021) Niyati Lobo et al. Nature Reviews Urology
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipid nanoparticles for mRNA delivery
- (2021) Xucheng Hou et al. Nature Reviews Materials
- COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity
- (2021) Soo-Kyung Jeong et al. Vaccines
- Infectious disease in an era of global change
- (2021) Rachel E. Baker et al. NATURE REVIEWS MICROBIOLOGY
- Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
- (2021) Mayuresh M. Abhyankar et al. npj Vaccines
- A Systematic Approach to HIV-1 Vaccine Immunogen Selection
- (2020) Alexander Bontempo et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Prevention of tuberculosis in macaques after intravenous BCG immunization
- (2020) Patricia A. Darrah et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes
- (2020) Grace L. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Recent Progress on the Versatility of Virus-Like Particles
- (2020) Ciying Qian et al. Vaccines
- Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine
- (2020) Gerard Nuovo et al. Annals of Diagnostic Pathology
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies
- (2020) Atul Sharma et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial
- (2020) Jessica E Manning et al. LANCET
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
- (2020) Luis E. Escobar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced Oral Vaccine Efficacy of Polysaccharide-Coated Calcium Phosphate Nanoparticles
- (2020) Pei Cao et al. ACS Omega
- Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study
- (2020) Joseph E Tota et al. JOURNAL OF INFECTIOUS DISEASES
- Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
- (2020) Aleksandra Zielińska et al. MOLECULES
- The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems
- (2020) Dheeraj Soni et al. PEDIATRIC RESEARCH
- NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
- (2020) Mimi Guebre-Xabier et al. VACCINE
- Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection
- (2020) Kayla Frank et al. Frontiers in Cellular and Infection Microbiology
- MPL Adjuvant Contains Competitive Antagonists of Human TLR4
- (2020) Yi-Qi Wang et al. Frontiers in Immunology
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
- (2020) Tsun-Yung Kuo et al. Scientific Reports
- Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
- (2019) Neal Whitaker et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine: Pooled Analysis of Safety in Older Adults ≥65 Years of Age
- (2019) Kelly Lindert et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Selection of adjuvants for vaccines targeting specific pathogens
- (2019) Indranil Sarkar et al. Expert Review of Vaccines
- Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: a review
- (2019) Marie-Aleth Lacaille-Dubois PHYTOMEDICINE
- Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family
- (2019) Christopher B. Fox et al. PHYTOMEDICINE
- Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
- (2019) Shuting Shi et al. VACCINE
- Cholera toxin promotes pathogen acquisition of host-derived nutrients
- (2019) Fabian Rivera-Chávez et al. NATURE
- An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines
- (2019) Michael I. Hauser et al. VACCINE
- Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
- (2019) Mansi Saxena et al. Frontiers in Immunology
- Vaccine Evolution and Its Application to Fight Modern Threats
- (2019) Emanuele Andreano et al. Frontiers in Immunology
- Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools
- (2019) Sanae Ben Mkaddem et al. Frontiers in Immunology
- Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
- (2019) Zheng Quan Toh et al. Infection and Drug Resistance
- Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems Against Group A Streptococcus
- (2019) Azuar et al. Vaccines
- Type I and type III interferons differ in their adjuvant activities for influenza vaccines
- (2019) Liang Ye et al. JOURNAL OF VIROLOGY
- Immune adjuvant therapy using Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) in advanced malignancies
- (2019) Sumiyuki Nishida et al. MEDICINE
- Metabolic Profiling and Compound-Class Identification Reveal Alterations in Serum Triglyceride Levels in Mice Immunized with Human Vaccine Adjuvant Alum
- (2019) Sakda Khoomrung et al. JOURNAL OF PROTEOME RESEARCH
- Herpes simplex virus latency is noisier the closer we look
- (2019) Navneet Singh et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
- (2019) Sonya Abraham et al. LANCET INFECTIOUS DISEASES
- Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus–16/18 Vaccine in Four- to Six-year-old Girls
- (2019) Lan Lin et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines
- (2019) Zheng Jin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Induction of specific adaptive immune responses by immunization with newly designed artificial glycosphingolipids
- (2019) Tetsuya Okuda et al. Scientific Reports
- Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
- (2018) Lutz Nuhn et al. BIOMATERIALS
- The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses
- (2018) Ewa Oleszycka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Flagellin as a vaccine adjuvant
- (2018) Baofeng Cui et al. Expert Review of Vaccines
- A Guide to IL-1 family cytokines in adjuvanticity
- (2018) Natalia Muñoz-Wolf et al. FEBS Journal
- Applications of chemokines as adjuvants for vaccine immunotherapy
- (2018) Teena Mohan et al. IMMUNOBIOLOGY
- Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
- (2018) Sofia E. Magnusson et al. IMMUNOLOGIC RESEARCH
- Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
- (2018) Kumar Vijay INTERNATIONAL IMMUNOPHARMACOLOGY
- Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine
- (2018) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
- (2018) Elisa Nemes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults
- (2018) Sam Jackson et al. VACCINE
- Immunology and efficacy of MF59-adjuvanted vaccines
- (2018) Eun-Ju Ko et al. Human Vaccines & Immunotherapeutics
- Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
- (2018) Yong Gao et al. Frontiers in Immunology
- The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
- (2018) Rhea N. Coler et al. npj Vaccines
- Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
- (2018) Alba Torrents de la Peña et al. Retrovirology
- Polysaccharides as vaccine adjuvants
- (2018) Beini Sun et al. VACCINE
- The adjuvant GLA-AF enhances human intradermal vaccine responses
- (2018) Darrick Carter et al. Science Advances
- Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice
- (2018) Jinqiu Zhang et al. BMC Veterinary Research
- Recent clinical trends in Toll-like receptor targeting therapeutics
- (2018) Muhammad Ayaz Anwar et al. MEDICINAL RESEARCH REVIEWS
- A malaria vaccine adjuvant based on recombinant antigen binding to liposomes
- (2018) Wei-Chiao Huang et al. Nature Nanotechnology
- Immunocorrelates of CAF family adjuvants
- (2018) Gabriel Kristian Pedersen et al. SEMINARS IN IMMUNOLOGY
- Correlates of GLA family adjuvants’ activities
- (2018) Steven G. Reed et al. SEMINARS IN IMMUNOLOGY
- Role of Papain-Like Cysteine Proteases in Plant Development
- (2018) Huijuan Liu et al. Frontiers in Plant Science
- Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
- (2018) Harm HogenEsch et al. npj Vaccines
- Calcium phosphate nanoparticles as a new generation vaccine adjuvant
- (2017) Yahua Lin et al. Expert Review of Vaccines
- 9-Valent human papillomavirus vaccine: a review of the clinical development program
- (2017) Alain Luxembourg et al. Expert Review of Vaccines
- Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles
- (2017) Guangsheng Du et al. JOURNAL OF CONTROLLED RELEASE
- Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials
- (2017) Maria Norrby et al. VACCINE
- Immune protection conferred by recombinant MRLC (myosin regulatory light chain) antigen in TiterMax Gold® adjuvant against experimental fasciolosis in rats
- (2017) Luan C. Henker et al. VACCINE
- Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
- (2017) John J. Suschak et al. Human Vaccines & Immunotherapeutics
- The Role of Interferons in Inflammation and Inflammasome Activation
- (2017) Nataša Kopitar-Jerala Frontiers in Immunology
- A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
- (2017) Neal Van Hoeven et al. Scientific Reports
- Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis
- (2016) Alberto Fernández-Tejada et al. ACCOUNTS OF CHEMICAL RESEARCH
- Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus
- (2016) Khairunnisa Abdul Ghaffar et al. Acta Biomaterialia
- Vaccine technologies: From whole organisms to rationally designed protein assemblies
- (2016) Christopher P. Karch et al. BIOCHEMICAL PHARMACOLOGY
- Adjuvant system AS01: helping to overcome the challenges of modern vaccines
- (2016) Arnaud M. Didierlaurent et al. Expert Review of Vaccines
- A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model
- (2016) Beth C. Holbrook et al. JOURNAL OF IMMUNOLOGY
- Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge
- (2016) Shinji Kasahara et al. JOURNAL OF INFECTIOUS DISEASES
- A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
- (2016) Joanne M. Langley et al. JOURNAL OF INFECTIOUS DISEASES
- A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents
- (2016) Derek Muse et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men
- (2016) Pierre Van Damme et al. VACCINE
- Strain-specific Plasmodium falciparum multifunctional CD4 + T cell cytokine expression in Malian children immunized with the FMP2.1/AS02 A vaccine candidate
- (2016) Shawna F. Graves et al. VACCINE
- From discovery to licensure, the Adjuvant System story
- (2016) Nathalie Garçon et al. Human Vaccines & Immunotherapeutics
- Nanomaterial-based vaccine adjuvants
- (2016) Bingbing Sun et al. Journal of Materials Chemistry B
- Adjuvants: Classification,Modus Operandi, and Licensing
- (2016) Juliana de Souza Apostólico et al. Journal of Immunology Research
- Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins
- (2016) Lynda Tussey et al. Open Forum Infectious Diseases
- The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction
- (2016) Natasha Dubois Cauwelaert et al. PLoS One
- B cells responses and cytokine production are regulated by their immune microenvironment
- (2015) Monica I. Vazquez et al. CYTOKINE
- Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
- (2015) Nikolai Petrovsky DRUG SAFETY
- Biosynthetically engineered lipopolysaccharide as vaccine adjuvant
- (2015) Afshin Zariri et al. Expert Review of Vaccines
- A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age
- (2015) Gregory M. Glenn et al. JOURNAL OF INFECTIOUS DISEASES
- Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants
- (2015) Jinyoung Lee et al. PARASITOLOGY RESEARCH
- ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans
- (2015) Ka Yan Chung et al. VACCINE
- Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques
- (2015) Kathryn Patton et al. VACCINE
- Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future
- (2015) Yotam Levin et al. Human Vaccines & Immunotherapeutics
- Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review
- (2015) Eva van Doorn et al. Human Vaccines & Immunotherapeutics
- Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study
- (2015) Barbara Romanowski et al. Human Vaccines & Immunotherapeutics
- Methods for Obtaining and Determination of Squalene from Natural Sources
- (2015) Ovidiu Popa et al. Biomed Research International
- Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant
- (2015) Miriam Tendler et al. Frontiers in Immunology
- Recent Advances of Vaccine Adjuvants for Infectious Diseases
- (2015) Sujin Lee et al. Immune Network
- Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients
- (2014) Maikel V. W. van der Velden et al. Clinical and Vaccine Immunology
- Metabolic and functional diversity of saponins, biosynthetic intermediates and semi-synthetic derivatives
- (2014) Tessa Moses et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial
- (2014) Lee-Jah Chang et al. LANCET
- Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery
- (2014) Vincent Pavot et al. Nanomedicine
- The contribution of vaccination to global health: past, present and future
- (2014) B. Greenwood PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
- (2014) Alex J. Mann et al. PLoS One
- Novel Mucosal DNA-MVA HIV Vaccination in Which DNA-IL-12 Plus Cholera Toxin B Subunit (CTB) Cooperates to Enhance Cellular Systemic and Mucosal Genital Tract Immunity
- (2014) Cynthia Maeto et al. PLoS One
- Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans
- (2014) Edgar Turner Overton et al. VACCINE
- Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
- (2014) David Gordon et al. VACCINE
- Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
- (2014) Julia Scheiermann et al. VACCINE
- A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
- (2014) Jaap T. van Dissel et al. VACCINE
- Modern Subunit Vaccines: Development, Components, and Research Opportunities
- (2013) Peter Michael Moyle et al. ChemMedChem
- Clinical vaccine development for H5N1 influenza
- (2013) Christopher H Clegg et al. Expert Review of Vaccines
- An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants
- (2013) Christopher B Fox et al. Expert Review of Vaccines
- Adjuvant Activity of Naturally Occurring Monophosphoryl Lipopolysaccharide Preparations from Mucosa-Associated Bacteria
- (2013) Paula M. Chilton et al. INFECTION AND IMMUNITY
- Vaccine-Induced Protection Against Murine Schistosomiasis Mansoni with Larval Excretory–Secretory Antigens and Papain or Type-2 Cytokines
- (2013) Rashika El Ridi et al. JOURNAL OF PARASITOLOGY
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers
- (2013) Robert J. Hopkins et al. VACCINE
- A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
- (2013) Rogier W. Sanders et al. PLoS Pathogens
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants
- (2013) Harm HogenEsch Frontiers in Immunology
- Mechanisms of Action of Adjuvants
- (2013) Sunita Awate et al. Frontiers in Immunology
- GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis
- (2012) Przemyslaw Blyszczuk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Structure of Immune Stimulating Complex Matrices and Immune Stimulating Complexes in Suspension Determined by Small-Angle X-Ray Scattering
- (2012) Jan Skov Pedersen et al. BIOPHYSICAL JOURNAL
- The history of MF59®adjuvant: a phoenix that arose from the ashes
- (2012) Derek T O’Hagan et al. Expert Review of Vaccines
- Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine
- (2012) Kae Pusic et al. FASEB JOURNAL
- ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases
- (2012) A. Baz Morelli et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Liposome-based delivery system for vaccine candidates: constructing an effective formulation
- (2012) Ashwini Kumar Giddam et al. Nanomedicine
- Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults
- (2012) Spyros A. Kalams et al. PLoS One
- The mechanism of action of MF59 – An innately attractive adjuvant formulation
- (2012) D.T. O’Hagan et al. VACCINE
- Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against Pneumonic Plague
- (2011) Devender Kumar et al. Clinical and Vaccine Immunology
- DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS
- (2011) Franco Lori Expert Review of Vaccines
- IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use
- (2011) Paola Rizza et al. Expert Review of Vaccines
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use
- (2011) Pin-Yu Perera et al. MICROBES AND INFECTION
- Norovirus Vaccine against Experimental Human Norwalk Virus Illness
- (2011) Robert L. Atmar et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)
- (2011) David N. Taylor et al. VACCINE
- Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
- (2011) Christine B. Turley et al. VACCINE
- Toll-Like Receptor Agonists
- (2010) Sacha Gnjatic et al. CANCER JOURNAL
- Invariant natural killer T cells: bridging innate and adaptive immunity
- (2010) Luc Van Kaer et al. CELL AND TISSUE RESEARCH
- Toll-Like Receptors: Cost or Benefit for Cancer?
- (2010) T. Matijevic et al. CURRENT PHARMACEUTICAL DESIGN
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Plasmodium vivax Ookinete Surface Protein Pvs25 Linked to Cholera Toxin B Subunit Induces Potent Transmission-Blocking Immunity by Intranasal as Well as Subcutaneous Immunization
- (2010) T. Miyata et al. INFECTION AND IMMUNITY
- Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
- (2010) Ryo Konno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Interleukin-1 Family Cytokines as Mucosal Vaccine Adjuvants for Induction of Protective Immunity against Influenza Virus
- (2010) H. Kayamuro et al. JOURNAL OF VIROLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine
- (2010) Sandhya Vasan et al. PLoS One
- A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
- (2010) Rhea N. Coler et al. PLoS One
- Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax
- (2010) S. K. Datta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell mediated immune responses in chickens
- (2010) Sanganagouda Koppad et al. RESEARCH IN VETERINARY SCIENCE
- Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults
- (2010) John J. Treanor et al. VACCINE
- Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
- (2010) Larry R. Smith et al. VACCINE
- Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice
- (2009) Hui Hu et al. BIOTECHNOLOGY LETTERS
- The epidemiology of primary amoebic meningoencephalitis in the USA, 1962–2008
- (2009) J. S. YODER et al. EPIDEMIOLOGY AND INFECTION
- The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents
- (2009) Amani Makkouk et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations
- (2009) Dennis Christensen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Neonatal Sublingual Vaccination with Salmonella Proteins and Adjuvant Cholera Toxin or CpG Oligodeoxynucleotides Induces Mucosal and Systemic Immunity in Mice
- (2009) Ching-Feng Huang et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
- (2009) Mark E. Polhemus et al. PLoS One
- IC31®, a Two-Component Novel Adjuvant Mixed with a Conjugate Vaccine Enhances Protective Immunity against Pneumococcal Disease in Neonatal Mice
- (2009) T. A. Olafsdottir et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination
- (2009) Fleur Aline et al. VACCINE
- Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans
- (2009) Robert B. Couch et al. VACCINE
- Calcium phosphate nanoparticle prepared with foot and mouth disease virus P1-3CD gene construct protects mice and guinea pigs against the challenge virus
- (2009) Dechamma Hosur Joyappa et al. VETERINARY MICROBIOLOGY
- Myeloid Differentiation Protein-2–Dependent and –Independent Neutrophil Accumulation duringEscherichia coliPneumonia
- (2008) Shanshan Cai et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Adjuvant activity of type I interferons
- (2008) Michael G. Tovey et al. BIOLOGICAL CHEMISTRY
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates
- (2008) S. B. Mizel et al. Clinical and Vaccine Immunology
- Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine after Priming with an Antigenic Variant
- (2008) Nega Ali Goji et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccine adjuvants: Current challenges and future approaches
- (2008) Jennifer H. Wilson-Welder et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications
- (2008) Jasjeet K. Sahni et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
- (2008) Fiona M. Thompson et al. PLoS One
- Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
- (2008) Gregory E. D. Mullen et al. PLoS One
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
- (2008) Else Marie Agger et al. PLoS One
- Effect of sublingual administration of interferon-α on the immune response to influenza vaccination in institutionalized elderly individuals
- (2008) Odile Launay et al. VACCINE
- Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
- (2008) Hans C. Rümke et al. VACCINE
- History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story
- (2007) Harry W. Herr et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More